Headache & Pain

Filter Your Results

 

News

 

The Prevalence of Migraine and Other Neurological Conditions Among Retired National Football League Players: A Pilot Study

Randolph W. Evans, MD

November/December 2017—Findings suggest that retired NFL players may be at increased risk for migraine, depression, anxiety, chronic pain, bedwetting, essential tremor, and Parkinson’s disease.

Forward Thinking: Advances in Neurology

November/December 2017—A review of notable neurological developments in 2017 and a preview of the year ahead.

Once-Daily Lyrica Formulation Wins FDA Approval

Thursday, October 12, 2017—The FDA has approved Lyrica CR (pregabalin, Pfizer) extended-release tablets CV as once-daily therapy for the management of neuropathic pain associated with diabetic periphera…

FDA Approves Intellis Device for Intractable Pain

Wednesday, September 20, 2017—The FDA has approved the Intellis platform (Medtronic) for the management of certain types of chronic intractable pain. The Intellis platform was designed to overcome limitati…

Aches and Trauma: Understanding Post-Traumatic Headache, Part 2: Management and Treatment

Francis X. Conidi, DO, MS

September 2017—Despite limited options for the treatment of post-traumatic headache, some evidence suggests potential for select therapies.

Aches and Trauma: Understanding Post-Traumatic Headache, Part 1 of 2: Diagnosis and Pathophysiology

Francis X. Conidi, DO, MS

July/August 2017—Findings increasingly suggest a pathophysiological link between concussion and headache, with implications for how neurologists approach both conditions.

Non-Invasive Neuromodulation Device for Chronic Intractable Pain Cleared by FDA

Tuesday, August 01, 2017—The FDA has cleared the Stimpod NMS460 (Xavant Technology), a non-invasive neuromodulation device for the symptomatic relief and management of chronic intractable pain. When a…

AHS 2017: Amgen’s CGRP Inhibitor Reduces Migraine Days

Tuesday, June 13, 2017—New Phase 2 data show that Amgen’s investigational investigational CGRP inhibitor erenumab is effective at preventing migraine in patients experiencing 15 or more migrai…

 
 

Contact Info

For advertising rates and opportunities:
Wendy Terry
Publisher
217-652-3859
wterry@bmctoday.com

About Practical Neurology

Launched in January 2002, Practical Neurology strives to enhance quality of care and improve the daily operation of neurology practices. Each month, our experts explain the real-world significance of recent advances in neurologic science and offer step-by-step advice on how to overcome the clinical and business challenges neurologists face. Our straightforward, how-to articles give neurologists tools they can put into practice right away.

 
  • BRYN MAWR COMMUNICATIONS III, LLC